Skip to main content
Alembic Pharmaceuticals Limited (BOM:533573)
India flag India · Delayed Price · Currency is INR
759.85
-4.20 (-0.55%)
At close: Apr 28, 2026

Alembic Pharmaceuticals Revenue

Alembic Pharmaceuticals had revenue of 18.76B INR in the quarter ending December 31, 2025, with 10.84% growth. This brings the company's revenue in the last twelve months to 72.67B, up 13.20% year-over-year. In the fiscal year ending March 31, 2025, Alembic Pharmaceuticals had annual revenue of 66.72B with 7.12% growth.

Revenue (ttm)
72.67B
Revenue Growth
+13.20%
P/S Ratio
2.05
Revenue / Employee
4.39M
Employees
16,571
Market Cap
149.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202566.72B4.43B7.12%
Mar 31, 202462.29B5.76B10.19%
Mar 31, 202356.53B3.47B6.54%
Mar 31, 202253.06B-873.40M-1.62%
Mar 31, 202153.93B7.87B17.10%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jubilant Pharmova 79.18B
Rubicon Research 15.98B
Caplin Point Laboratories 20.92B
Granules India 50.92B
AstraZeneca Pharma India 21.77B
CORONA Remedies 13.44B
Viyash Scientific 18.17B
Procter & Gamble Health 13.49B
Revenue Rankings

Alembic Pharmaceuticals News

More News